Update on New and Emerging Treatments for Schizophrenia.
Publication/Presentation Date
6-1-2016
Abstract
Although there has been more than 50 years of development, there remains a great need for better antipsychotic medications. This article looks at the recent advances in treatment of schizophrenia. New hypotheses have been suggested that may replace or complement the dopamine hypotheses. The article explores the different novel drugs that impact some of the key neurotransmitter systems currently. Phosphodiesterase 10A inhibitors and α-7 neuronal nicotinic acetylcholine receptor modulators constitute the majority. The marketing of these medications eventually may result in change about how schizophrenia is treated.
Volume
39
Issue
2
First Page
217
Last Page
238
ISSN
1558-3147
Published In/Presented At
Gopalakrishna, G., Ithman, M. H., & Lauriello, J. (2016). Update on New and Emerging Treatments for Schizophrenia. The Psychiatric clinics of North America, 39(2), 217–238. https://doi.org/10.1016/j.psc.2016.01.005
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
27216901
Department(s)
Administration and Leadership
Document Type
Article